BeyondSpring Inc. Increase (Decrease) in Accrued Liabilities
BeyondSpring Inc. (BYSI) reported Increase (Decrease) in Accrued Liabilities of -$595.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-14
- BeyondSpring Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $800.00K, a 788.89% increase year-over-year.
- BeyondSpring Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$1.40M, a 269.09% decline year-over-year.
- BeyondSpring Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $510.00K, a 3.45% increase year-over-year.
- BeyondSpring Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $417.00K.
- BeyondSpring Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $1.84M.
- BeyondSpring Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$387.00K, a 448.65% decline from fiscal 2023.
- BeyondSpring Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $111.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$595.00K 10-Q · filed 2026-08-14 | -$85.00K derived: sum of 3 quarters · filed 2026-08-14 | $332.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$1.40M 10-Q · filed 2026-05-13 | -$885.00K derived: sum of 2 quarters · filed 2026-05-13 | -$468.00K derived: sum of 3 quarters · filed 2026-05-13 | -$378.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $510.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $927.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.02M derived: sum of 3 quarters · filed 2026-08-14 | $1.84M 10-K · filed 2026-03-25 |
| 2025-09-30 | $417.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $507.00K derived: sum of 2 quarters · filed 2026-08-14 | $1.33M 10-Q · filed 2025-11-12 | $1.82M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $915.00K 10-Q · filed 2026-08-14 | $1.41M derived: sum of 3 quarters · filed 2026-08-14 | $1.35M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $825.00K 10-Q · filed 2026-05-13 | $1.32M derived: sum of 2 quarters · filed 2026-05-13 | $1.26M derived: sum of 3 quarters · filed 2026-05-13 | $1.73M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $493.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $440.00K derived: sum of 2 quarters · filed 2026-03-25 | $901.00K derived: sum of 3 quarters · filed 2026-03-25 | -$387.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | -$53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $408.00K derived: sum of 2 quarters · filed 2025-11-12 | -$880.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $461.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$827.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$1.29M 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $111.00K 10-K · filed 2025-03-27 | |||
| 2022-12-31 | -$1.39M 20-F · filed 2023-04-18 | |||
| 2021-12-31 | -$3.33M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | -$3.35M derived: sum of 2 quarters · filed 2023-04-18 | -$1.90M derived: sum of 3 quarters · filed 2023-04-18 | -$1.71M 20-F · filed 2023-04-18 |
| 2021-09-30 | -$25.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $1.43M derived: sum of 2 quarters · filed 2021-12-30 | $1.62M 6-K · filed 2021-12-30 | -$1.19M derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-06-30 | $1.46M derived: 6-K 6 month − 6-K 3 month · filed 2021-09-10 | $1.64M 6-K · filed 2021-09-10 | -$1.17M derived: sum of 3 quarters · filed 2023-04-18 | $26.00K derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-03-31 | $187.00K 6-K · filed 2021-06-16 | -$2.62M derived: sum of 2 quarters · filed 2023-04-18 | -$1.43M derived: sum of 3 quarters · filed 2023-04-18 | $1.06M derived: sum of 4 quarters · filed 2023-04-18 |
| 2020-12-31 | -$2.81M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | -$1.62M derived: sum of 2 quarters · filed 2023-04-18 | $873.00K derived: sum of 3 quarters · filed 2023-04-18 | -$291.00K 20-F · filed 2023-04-18 |
| 2020-09-30 | $1.19M derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $3.68M derived: sum of 2 quarters · filed 2021-12-30 | $2.52M 6-K · filed 2021-12-30 | $3.59M derived: sum of 4 quarters · filed 2022-04-14 |
| 2020-06-30 | $2.49M derived: 6-K 6 month − 6-K 3 month · filed 2021-09-10 | $1.33M 6-K · filed 2021-09-10 | $2.40M derived: sum of 3 quarters · filed 2022-04-14 | $1.10M derived: sum of 4 quarters · filed 2022-04-14 |
| 2020-03-31 | -$1.16M 6-K · filed 2021-06-16 | -$93.00K derived: sum of 2 quarters · filed 2022-04-14 | -$1.39M derived: sum of 3 quarters · filed 2022-04-14 | -$3.17M derived: sum of 4 quarters · filed 2022-04-14 |
| 2019-12-31 | $1.07M derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | -$223.00K derived: sum of 2 quarters · filed 2022-04-14 | -$2.01M derived: sum of 3 quarters · filed 2022-04-14 | $366.00K 20-F · filed 2022-04-14 |
| 2019-09-30 | -$1.29M derived: 6-K 9 month − 6-K 6 month · filed 2020-11-17 | -$3.08M derived: sum of 2 quarters · filed 2020-11-17 | -$705.00K 6-K · filed 2020-11-17 | -$2.15M derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-06-30 | -$1.79M derived: 6-K 6 month − 6-K 3 month · filed 2020-09-03 | $589.00K 6-K · filed 2020-09-03 | -$860.00K derived: sum of 3 quarters · filed 2021-04-30 | $4.16M derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-03-31 | $2.38M 6-K · filed 2020-06-11 | $928.00K derived: sum of 2 quarters · filed 2021-04-30 | $5.95M derived: sum of 3 quarters · filed 2021-04-30 | $6.76M derived: sum of 4 quarters · filed 2021-04-30 |
| 2018-12-31 | -$1.45M derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | $3.57M derived: sum of 2 quarters · filed 2021-04-30 | $4.38M derived: sum of 3 quarters · filed 2021-04-30 | $4.69M 20-F · filed 2021-04-30 |
| 2018-09-30 | $5.02M derived: 6-K 9 month − 6-K 6 month · filed 2019-12-18 | $5.83M derived: sum of 2 quarters · filed 2019-12-18 | $6.14M 6-K · filed 2019-12-18 | $5.62M derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-06-30 | $814.00K derived: 6-K 6 month − 6-K 3 month · filed 2019-09-18 | $1.12M 6-K · filed 2019-09-18 | $604.00K derived: sum of 3 quarters · filed 2020-04-30 | $1.34M derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-03-31 | $305.00K 6-K · filed 2019-07-10 | -$210.00K derived: sum of 2 quarters · filed 2020-04-30 | $528.00K derived: sum of 3 quarters · filed 2020-04-30 | $1.10M derived: sum of 4 quarters · filed 2020-04-30 |
| 2017-12-31 | -$515.00K derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | $223.00K derived: sum of 2 quarters · filed 2020-04-30 | $796.00K derived: sum of 3 quarters · filed 2020-04-30 | $699.00K 20-F · filed 2020-04-30 |
| 2017-09-30 | $738.00K derived: 6-K 9 month − 6-K 6 month · filed 2017-11-09 | $1.31M derived: sum of 2 quarters · filed 2018-10-23 | $1.21M 6-K · filed 2017-11-09 | $1.07M derived: sum of 4 quarters · filed 2019-04-30 |
| 2017-06-30 | $573.00K derived: 6-K 6 month − 6-K 3 month · filed 2018-10-23 | $476.00K 6-K · filed 2018-10-23 | $333.00K derived: sum of 3 quarters · filed 2019-04-30 | $582.00K derived: sum of 4 quarters · filed 2019-04-30 |
| 2017-03-31 | -$97.00K 6-K · filed 2018-06-21 | -$240.00K derived: sum of 2 quarters · filed 2019-04-30 | $9.00K derived: sum of 3 quarters · filed 2019-04-30 | -$79.00K derived: sum of 4 quarters · filed 2019-04-30 |
| 2016-12-31 | -$143.00K derived: 20-F 12 month − 6-K 9 month · filed 2019-04-30 | $106.00K derived: sum of 2 quarters · filed 2019-04-30 | $18.00K derived: sum of 3 quarters · filed 2019-04-30 | -$102.00K 20-F · filed 2019-04-30 |
| 2016-09-30 | $249.00K derived: 6-K 9 month − 6-K 6 month · filed 2017-11-09 | $161.00K derived: sum of 2 quarters · filed 2017-11-09 | $41.00K 6-K · filed 2017-11-09 | |
| 2016-06-30 | -$88.00K derived: 6-K 6 month − 6-K 3 month · filed 2017-08-21 | -$208.00K 6-K · filed 2017-08-21 | ||
| 2016-03-31 | -$120.00K 6-K · filed 2017-05-22 | |||
| 2015-12-31 | $210.00K 20-F · filed 2018-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |